Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study

AIMS: Nonvitamin K antagonist oral anticoagulants (NOACs) are now available for the prevention of stroke in patients with atrial fibrillation (AF) as an alternative to vitamin K antagonists (VKA) and aspirin. The comparative effectiveness and safety in daily practice of these different drug classes...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Clin Pharmacol
Autors principals: Gieling, Emilie M., van den Ham, Hendrika A., van Onzenoort, Hein, Bos, Jacqueline, Kramers, Cornelis, de Boer, Anthonius, de Vries, Frank, Burden, Andrea M.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2017
Matèries:
Pharmacoepidemiology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510083/
https://ncbi.nlm.nih.gov/pubmed/28205318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13265
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars